Xometry Announces Proposed $225M Public Offering of Class A Common Stock
Summary
Xometry has filed a preliminary prospectus supplement for a proposed $225 million public offering of Class A common stock, which will be dilutive to existing shareholders, following a universal shelf registration and recent insider selling.
Key Events
-
Proposed Public Offering
Xometry is offering $225,000,000 of Class A common stock, with underwriters having an option to purchase an additional $33,750,000 in shares.
-
Potential for Substantial Dilution
The filing explicitly states that investors purchasing shares in this offering will experience immediate and substantial dilution of their investment. The offering size is approximately 4.5% of the company's current market capitalization.
-
Use of Proceeds
Net proceeds are intended for working capital and general corporate purposes, including repayment of debt, capital expenditures, and potential acquisitions.
-
Follows Shelf Registration
This 424B5 prospectus supplement finalizes the terms of an offering initiated under a universal shelf registration (S-3ASR) filed earlier today, June 1, 2026.
Analysis
Xometry is initiating a substantial capital raise of $225 million through a public offering of Class A common stock, with an option for underwriters to purchase an additional $33.75 million. This offering represents a significant potential dilution for existing shareholders, as explicitly stated in the filing. While the final offering price is not yet determined, the magnitude of the raise (approximately 4.5% of the current market capitalization) is notable. This capital raise follows a universal shelf registration filed earlier today and occurs amidst recent insider selling activity, including a $4.39 million sale by the CEO last week, which may raise questions about management's conviction despite strong recent financial results and a strategic partnership with Siemens.
At the time of this filing, XMTR was trading at $87.55 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $5B. The 52-week trading range was $29.60 to $99.86. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.